This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. And the datasets analyzed during the current study are available in the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) portal (https://ocg.cancer.gov/programs/target).
Hollink IHIM, van den Heuvel-Eibrink MM, Arentsen-Peters STCJM, Pratcorona M, Abbas S, Kuipers JE, et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood. 2011;118:3645–56.
Bisio V, Zampini M, Tregnago C, Manara E, Salsi V, Di Meglio A, et al. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group. Leukemia 2017;31:974–7.
Struski S, Lagarde S, Bories P, Puiseux C, Prade N, Cuccuini W, et al. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 2017;31:565–72.
Huber S, Baer C, Hutter S, Dicker F, Meggendorfer M, Pohlkamp C, et al. AML classification in the year 2023: How to avoid a Babylonian confusion of languages. Leukemia 2023;37:1413–20.
Chen X, Wang F, Zhang Y, Ma XL, Cao PX, Yuan LL, et al. Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer J. 2021;11:112.
Stengel A, Nadarajah N, Haferlach T, Dicker F, Kern W, Meggendorfer M, et al. Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing. Leukemia 2018;32:1229–38.
Stengel A, Shahswar R, Haferlach T, Walter W, Hutter S, Meggendorfer M, et al. Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS. Blood Adv. 2020;4:5393–401.
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) portal https://ocg.cancer.gov/programs/target.
Cheng ZH, Dai YF, Zeng TS, Liu Y, Cui LZ, Qian TT, et al. Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia. Front Oncol. 2020;10:379.
Ren ZH, Kim A, Huang YT, Pi WC, Gong WD, Yu XF, et al. A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia. P Natl Acad Sci USA. 2022;119:e2122940119.
Liu H, Wang M, Li M, Wang DH, Rao Q, Wang Y, et al. Expression and role of DJ-1 in leukemia. Biochem Bioph Res Co. 2008;375:477–83.
Jin ZJ, Huang WJ, Shen N, Li J, Wang XC, Dong J, et al. Single-cell gene fusion detection by scFusion. Nat Commun. 2022;13:1084.
Wu CY, Li YL, Dong XY, Zhang L, Shang BJ, Li W, et al. Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review. Zhonghua Xue Ye Xue Za Zhi. 2020;41:595–8.
Lim HJ, Lee JH, Lee YE, Baek HJ, Kook H, Park JH, et al. The First Korean Case of NUP98-NSD1 and a Novel SNRK-ETV6 Fusion in a Pediatric Therapy-related Acute Myeloid Leukemia Patient Detected by Targeted RNA Sequencing. Ann Lab Med. 2021;41:443–6.
Abe A, Yamamoto Y, Iba S, Kanie T, Okamoto A, Tokuda M, et al. ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9. Genes Chromosom Cancer. 2016;55:242–50.
Salsi V, Ferrari S, Gorello P, Fantini S, Chiavolelli F, Mecucci C, et al. NUP98 fusion oncoproteins promote aneuploidy by attenuating the mitotic spindle checkpoint. Cancer Res. 2014;74:1079–90.
Domingo-Reines J, Montes R, Garcia-Moreno A, Gallardo A, Sanchez-Manas JM, Ellson I, et al. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation. Cell Death Dis. 2023;14:357.
This study was supported by grants from the Nation Natural Science Foundation of China (No. 82273942 to XJS), the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (No. LR23H310001 to MDY) and the Fundamental Research Funds for the Central Universities.
The authors declare no competing interests.
Ethics approval and consent to participate
Approval from the Institutional Research Ethics Committee of the hospital were obtained before the use of these clinical materials for research purposes. The Animal Research Committee at Zhejiang University approved all animal studies and animal care was provided in accordance with the institutional guidelines.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Du, W., Xia, Z., Luo, Z. et al. A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML. Leukemia 37, 2286–2291 (2023). https://doi.org/10.1038/s41375-023-02024-6